Transcarotid Artery Revascularization || Expanding the Patient Selection for Thrombectomy in Acute Stroke: The New Frontiers
Transcarotid Artery Revascularization
For several decades, carotid endarterectomy has been the criterion standard for carotid revascularization. This portion of the course will review results from recent trials that describe how transcarotid artery revascularization (TCAR) may be an ideal option for reducing the risk for peri-procedural stroke.
- Compare outcomes associated with transcarotid artery revascularization, transfemoral carotid artery stenting and carotid endarterectomy.
- Recognize recent trial results that describe how transcarotid artery revascularization may be an ideal option for reducing the risk for peri-procedural stroke.
Expanding the Patient Selection for Thrombectomy in Acute Stroke: The New Frontiers
It is possible that patients who are eligible for endovascular treatments with one selection method will be ineligible with other selection methods, which may lead to controversies in patient treatment decisions in clinical practice. This portion of the course will describe optimal patient selection for endovascular treatments.
- Recognize the beneficial effect of endovascular treatment with mechanical thrombectomy in acute ischemic stroke.
- Optimize patient selection for endovascular treatment in acute ischemic stroke.
- Describe the current imaging guideline recommendations for endovascular treatments in clinical practice.
Adult and Pediatric Neurologists, Neurosurgeons, Stroke Neurologists, Neuroradiologists, Diagnostic Radiologists, Critical Care Physicians, Neurointensivists, Emergency Medicine Physicians, Internal Medicine Physicians, Interventional Neuroradiologists, Family Physicians, General Internists, Physician Assistants, Critical Care and Neuroscience Nurses, Neurosurgery Nurses, Nurse Practitioners, Respiratory Therapists (Personal Growth), Pharmacists and Rehabilitation and Pain Management Specialists, as well as other specialists interested in the field of neuroscience.
Libby L. Watch, M.D.
Miami Cardiac & Vascular Institute
Guilherme Dabus, M.D., MBA, FAHA
Director, Neuroendovascular Surgery Fellowship
Miami Neuroscience Institute
Miami Cardiac & Vascular Institute
Baptist Health South Florida
Florida International University Herbert Wertheim College of Medicine
Libby L. Watch, M.D., disclosed that she is a member of the speakers bureau for Bard and that she will not include off-label or unapproved product usage in her presentation or discussion.
Guilherme Dabus, M.D., disclosed that he is a consultant and member of the speakers bureau for Medtronic, Microvention, Penumbra and Cerenovus, and that he is a shareholder in eLum, RIST, InNeuroCo, Deinde Medical, Synchron and Three Rivers. Dr. Dabus also disclosed that he will include off-label or unapproved product usage in his presentation or discussion.
Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.25 AMA PRA Category 1 Credit™
- 1.25 General certificate of attendance
- 1.00 Nurse Practitioners
- 1.00 Florida Board of Nursing
- 1.00 Florida Board of Pharmacy
- 1.00 Florida Board of Respiratory Therapy
This site is supported on the most recent stable releases of the following browsers:
This site is supported on the following mobile devices:
If you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.